GL1X · GenesisL1 explorer

Research workbench

PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z5265428226

Analyse PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5SRJ
Type
protein
Length
336 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.05
Source
Severe acute respiratory syndrome coronavirus 2
Molecule
Non-structural protein 3
EC
3.4.19.121, 3.4.22.-
UniProt
P0DTD1
Ligands
R9L
Pockets
3 · best druggability 0.67

Structure

x-ray diffraction · resolution 1.05 · 2 distinct chains · 41% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANon-structural protein 3 (EC 3.4.19.121, 3.4.22.-)protein16740% helix, 19% strandP0DTD1
BNon-structural protein 3 (EC 3.4.19.121, 3.4.22.-)protein16942% helix, 19% strandP0DTD1

Ligands and binding sites

  • R9L · 3-{[(7-fluoro-9H-pyrimido[4,5-b]indol-4-yl)amino]methyl}-1lambda~6~-thietane-1,1-dione · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14570.670.7935empty
21480.530.8024empty
31580.520.7932R9L

Interfaces

1 interface between chains.

  • A–B · 527 Ų buried · 20 hydrogen bonds · protein-protein

Compared structures

  • 5SRJ · Pandda analysis group deposition -- crystal structure of SARS-cov-2 NSP3 macrodomain in… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.